Neuroprotective effect of CPCGI on Alzheimer's disease and its mechanism.
Wang, Xiaopeng
Neuroprotective effect of CPCGI on Alzheimer's disease and its mechanism. [electronic resource] - Molecular medicine reports 01 2020 - 115-122 p. digital
Publication Type: Journal Article
1791-3004
10.3892/mmr.2019.10835 doi
Alzheimer Disease--drug therapy
Amyloid beta-Peptides--metabolism
Animals
Apoptosis--drug effects
Behavior Rating Scale
Cell Survival--drug effects
Interleukin-1beta--metabolism
MAP Kinase Signaling System--drug effects
Malondialdehyde--metabolism
NF-kappa B--metabolism
Neuroprotective Agents--pharmacology
Oxidative Stress--drug effects
PC12 Cells
Peptide Fragments--metabolism
Rats
Rats, Wistar
Reactive Oxygen Species--metabolism
Superoxide Dismutase-1--metabolism
Swine
Tumor Necrosis Factor-alpha--metabolism
Neuroprotective effect of CPCGI on Alzheimer's disease and its mechanism. [electronic resource] - Molecular medicine reports 01 2020 - 115-122 p. digital
Publication Type: Journal Article
1791-3004
10.3892/mmr.2019.10835 doi
Alzheimer Disease--drug therapy
Amyloid beta-Peptides--metabolism
Animals
Apoptosis--drug effects
Behavior Rating Scale
Cell Survival--drug effects
Interleukin-1beta--metabolism
MAP Kinase Signaling System--drug effects
Malondialdehyde--metabolism
NF-kappa B--metabolism
Neuroprotective Agents--pharmacology
Oxidative Stress--drug effects
PC12 Cells
Peptide Fragments--metabolism
Rats
Rats, Wistar
Reactive Oxygen Species--metabolism
Superoxide Dismutase-1--metabolism
Swine
Tumor Necrosis Factor-alpha--metabolism